Document:

Document

Exhibit 10.6

Alpine Immune Sciences, Inc.
Non-Employee Director Compensation Guidelines
As of March 2021
The purpose of these Non-Employee Director Compensation Guidelines (the “Guidelines”) of Alpine Immune Sciences, Inc., a Delaware corporation the (the “Company”), is to provide a total compensation package that enables the Company to attract, retain and reward, on a long-term basis, directors who are not employees or officers of the Company or its subsidiaries (“Outside Directors”) to serve on the Company’s Board of Directors (the “Board”).  A Board member who is also an officer or employee of the Company will not receive any Annual Cash Retainers or Equity Retainers for his or her service on the Board.  In furtherance of the purpose stated above, all Outside Directors shall be paid compensation for services provided to the Company as set forth below:
I.    Annual Cash Retainers

									
	A.	Annual Retainer for Board Membership: for general availability and participation in meetings and conference calls of our Board of Directors
	$	40,000 	
	B.	Additional Retainer for Board Chairman:
	$	25,000 	
	C.	Additional Retainers for Committee Membership:
	
		Audit Committee Chairperson: 
	$	15,000 	
		Audit Committee member: 
	$	7,500 	
		Compensation Committee Chairperson: 
	$	10,000 	
		Compensation Committee member: 
	$	5,000 	
		Nominating and Corporate Governance Committee Chairperson: 
	$	7,500 	
		Nominating and Corporate Governance Committee member: 
	$	3,750 	

Annual Cash Retainers are paid quarterly in arrears.  Any Outside Director that is appointed mid-fiscal year will receive his or her Annual Cash Retainer on a pro-rated basis. 
II.    Equity Retainers
All grants of equity retainer awards to Outside Directors pursuant to these Guidelines will be automatic and nondiscretionary and will be made in accordance with the following provisions:
A.Granting of Awards.
1.Initial Award.  Each individual who is first elected or appointed as an Outside Director shall automatically be granted, on the date of such initial election or appointment, a nonqualified stock option (the “Option”) to purchase 20,000 shares of the Company’s common stock (the “Initial Option”), pursuant to the equity plan in effect at the time of grant (the “Plan”). 
2.Annual Award.  On the first trading day in January of each year, each Outside Director who is continuing to serve as such shall automatically be granted an Option to purchase 10,000 shares of the Company’s common stock (the “Annual Option”), pursuant to the Plan.  There shall be no limit on the number of Annual Options that an Outside Director may receive over his or her period of Board service.

3.Award Agreement.  Each Option granted pursuant to these shall be evidenced by an agreement between the Outside Director and the Company in such form as the Board, the Committee or their respective authorized designee shall determine, which complies with the terms specified in these Guidelines (the “Option Agreement”). 
4.Exercise Price.  The exercise price per share of each Option shall be equal to one hundred percent (100%) of the Fair Market Value, as defined in the Plan, per share of the Company’s common stock on the grant date of the Option (the “Grant Date”). 
5.Option Term.  Each Option shall have a term of ten (10) years measured from the Grant Date. 
6.Vesting.  Subject to the other provisions of these Guidelines, the Plan and the Option Agreement: 
(a)Initial Options.  The shares subject to each Initial Option shall vest one thirty-sixth on each one-month anniversary of the Grant Date, such that the Option will be fully vested on the three-year anniversary of the Grant Date. 
(b)Annual Options.  The shares subject to each Annual Option shall vest one twelfth on each one-month anniversary of the Grant Date, such that the Option will be fully vested on the one-year anniversary of the Grant Date. 
7.Effect of Cessation of Board Service.  The following provisions shall govern the exercise of any Option held by an Outside Director at the time he or she ceases to serve as a Board member (the “Optionee”): 
(a)The Optionee shall have a three-month period following the date of such cessation of Board service (the “Termination Date”) in which to exercise any vested but unexercised portion of the Option if Optionee’s service terminates for any reason other than death, disability or cause.  If Optionee’s service terminates for cause, the Option will expire on the Termination Date.  If Optionee’s service terminates due to death or disability, the Optionee (or, in the event of the Optionee’s death, the personal representative of the Optionee’s estate or the person or persons to whom the Option is transferred pursuant to the Optionee’s will or in accordance with the laws of descent and distribution) shall have a six-month period following the Termination Date in which to exercise any vested but unexercised portion of the Option. 
(b)The unvested portion of the Option shall be cancelled as of the Termination Date.  During the post-Termination Date exercise period, if any, the Option may not be exercised for more than the number of shares of common stock in which the Optionee is vested at the time of his or her Termination Date. 
(c)In no event shall the Option remain exercisable after the expiration of the Option’s term. 
B.Approval of Grants.  The Board’s approval of these Guidelines shall constitute pre-approval of each Option granted under these Guidelines, and the subsequent exercise of such Option in accordance with the terms and conditions of these Guidelines, the Plan and the Option Agreement. 

C.Corporate Transaction or Change in Control.  In the event of a Corporate Transaction or Change in Control, as defined in the Plan, awards granted to Outside Directors pursuant to these Guidelines will be fully vested and exercisable immediately prior to the consummation of such Corporate Transaction or Change in Control.
D.Revisions.  The Board in its discretion may change and otherwise revise the terms of awards to be granted under these Guidelines, including, without limitation, the number of shares subject thereto, for awards of the same or different type granted on or after the date the Compensation Committee of the Board (the “Compensation Committee”) makes a recommendation of any such change or revision.
All equity grants under these Guidelines will be made automatically in accordance with the terms of these Guidelines, the Plan and the Option Agreement, without the need for any additional corporate action by the Board or the Compensation Committee. 
III.    Expenses
The Company will reimburse all reasonable out-of-pocket expenses incurred by Outside Directors in the performance as their duties as members of the Board, in accordance with the Company’s policy governing reimbursement of business expenses as in effect from time to time.EX-4.1

 Exhibit 4.1 

SPECIMEN UNIT CERTIFICATE 

NUMBER UNITS U-[·] 
  

					
	 SEE REVERSE
 FOR CERTAIN

DEFINITIONS
	  	Advancit Acquisition Corp. I	  	

 CUSIP [·] 
 UNITS CONSISTING OF ONE CLASS A ORDINARY SHARE AND ONE-THIRD OF 
 ONE REDEEMABLE WARRANT TO PURCHASE ONE CLASS A ORDINARY SHARE 

THIS CERTIFIES THAT                      is the
owner of                      Units. 
 Each Unit
(“Unit”) consists of one (1) Class A ordinary share, par value $0.0001 per share (“Ordinary Shares”), of Advancit Acquisition Corp. I., a Cayman Islands exempted company (the “Company”), and one-third (1/3rd) of one redeemable warrant (each whole warrant, a “Warrant”). Each Warrant entitles the holder to purchase one (1) Ordinary Share for $11.50 per share (subject to adjustment). Each
Warrant will become exercisable on the later of (i) thirty (30) days after the Company’s completion of a merger, share exchange, asset acquisition, share purchase, reorganization or other similar business combination with one or more
businesses (each, a “Business Combination”), and (ii) twelve (12) months from the closing of the Company’s initial public offering, and will expire unless exercised before 5:00 p.m., New York City Time, on the date that is five
(5) years after the date on which the Company completes its initial Business Combination, or earlier upon redemption or liquidation (the “Expiration Date”). The Ordinary Shares and Warrants comprising the Units represented by this
certificate are not transferable separately prior to [·], 2021, unless Citigroup Global Markets Inc. elects to allow earlier
separate trading, subject to the Company’s filing with the Securities and Exchange Commission of a Current Report on Form 8-K containing an audited balance sheet reflecting the Company’s receipt of the gross proceeds of the initial public
offering and issuing a press release announcing when separate trading will begin. No fractional warrants will be issued upon separation of the Units and only whole warrants are exercisable. The terms of the Warrants are governed by a Warrant
Agreement, dated as of [·], 2021, between the Company and Continental Stock Transfer & Trust Company, as Warrant
Agent, and are subject to the terms and provisions contained therein, all of which terms and provisions the holder of this certificate consents to by acceptance hereof. Copies of the Warrant Agreement are on file at the office of the Warrant Agent
at One State Street, 30th Floor, New York, New York 10004, and are available to any Warrant holder on written request and without cost. 

 Upon the consummation of the Business Combination, the Units represented by this certificate will
automatically separate into the Class A Ordinary Shares and Warrants comprising such Units. 
 This certificate is not valid unless countersigned by
the Transfer Agent and Registrar of the Company. 
 This certificate shall be governed by and construed in accordance with the internal laws of the State of
New York. 
 Witness the facsimile signatures of its duly authorized officers. 
  

									
	By	 	  
	 	                    	 	By	 	  

	Chief Executive Officer	 		 	Chief Financial Officer

 Advancit Acquisition Corp. I 

The Company will furnish without charge to each unitholder who so requests, a statement of the powers, designations, preferences and relative, participating,
optional or other special rights of each class of shares or series thereof of the Company and the qualifications, limitations or restrictions of such preferences and/or rights. 

The following abbreviations, when used in the inscription on the face of this certificate, shall be construed as though they were written out in full
according to applicable laws or regulations: 
  

					
	TEN COM — as tenants in common	  	 UNIF GIFT MIN ACT
 —
	  	Custodian
			
		  		  	(Cust)                (Minor)
			
	 TEN ENT — as tenants by the

entireties
	  		  	 under Uniform Gifts to

Minors Act

			
		  		  	(State)
			
	 JT TEN — as joint tenants with right of

survivorship and not as tenants in
 common
	  		  	

 Additional abbreviations may also be used though not in the above list. 

 For value received, hereby sells, assigns and transfers unto 

PLEASE INSERT SOCIAL SECURITY OR OTHER IDENTIFYING NUMBER OF 

ASSIGNEE 
 (PLEASE PRINT OR
TYPEWRITE NAME AND ADDRESS, INCLUDING ZIP CODE, OF 
 ASSIGNEE) 

                     Units represented by
the within Certificate, and do hereby irrevocably constitute and appoint                      as Attorney to transfer the said Units on the
books of the within named Company with full power of substitution in the premises. 
  

			
	Dated                     	  	 Notice: The signature to this assignment must

correspond with the name as written upon the
 face of the
certificate in every particular,
 without alteration or enlargement or any

change whatever.

 Signature(s) Guaranteed: THE SIGNATURE(S) MUST BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION (BANKS, STOCKBROKERS,
SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM, PURSUANT TO S.E.C. RULE 17Ad-15 OR ANY SUCCESSOR RULES). 

In each case, as more fully described in the Company’s final prospectus dated
[·], 2021, the holder(s) of this certificate shall be entitled to receive a pro-rata
portion of certain funds held in the trust account established in connection with the Company’s initial public offering only in the event that (i) the Company redeems the Ordinary Shares sold in its initial public offering and liquidates
because it does not consummate an initial business combination within the period of time set forth in the Company’s amended and restated memorandum and articles of association, as the same may be amended from time to time, (ii) the Company
redeems the Ordinary Shares sold in its initial public offering in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association (A) that would modify the substance or timing of the
Company’s obligation to provide holders of the Ordinary Shares the right to have their shares redeemed in connection with the Company’s initial business combination or to redeem 100% of the Ordinary Shares if the Company does not complete
its initial business combination within the time period set forth therein or (B) with respect to any other provision relating to the rights of holders of the Ordinary Shares, or (iii) if the holder(s) seek(s) to redeem for cash his, her or
its respective Ordinary Shares in connection with a tender offer (or proxy solicitation, solely in the event the Company seeks shareholder approval of the proposed initial business combination) setting forth the details of a proposed initial
business combination. In no other circumstances shall the holder(s) have any right or interest of any kind in or to the trust account.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00324-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00324-of-00352.parquet"}]]